Purchase Order 75N92024P00258

The National Heart Lung and Blood Institute (NHLBI), a component of the Department of Health and Human Services, awarded a $25,900 firm fixed-price purchase order contract to QPS LLC, a minority-owned limited liability company, for the "Evaluation of R406 Levels in a Non-Human Primate Model of Bacterial Sepsis." This research and development contract, awarded on March 6, 2025, supports NHLBI's efforts to study bacterial sepsis progression and potential therapeutic interventions using...

This is a purchase order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Quest Diagnostics Incorporated, a large for-profit diagnostic information services provider, for the collection and analysis of NHLBI research participant specimens. The contract has a ceiling value of $184,342.95 and is a time and materials type contract with a completion date of September 14, 2024. The original solicitation was for the collection and analysis of NHLBI...

<p>The National Heart, Lung and Blood Institute (NHLBI) issued a purchase order to Psomagen Inc. on May 14, 2026, valued at $199,994.72 for Olink Explore HT proteomic analysis supporting a sickle cell disease study. Work is performed in Rockville, Maryland, with an ultimate completion date of November 21, 2026. The purchase order is a firm fixed-price, severable contract with no set-aside designation.</p>

This is a $16,100.00 firm fixed price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to TRU Diagnostics Inc. The contract is to support research conducted by the Epidemiology and Community Health Branch (ECHB) and the Laboratory of Genomic Instability and Cardiopulmonary Outcomes (LOGICO) within the NHLBI's Division of Intramural Research. The contract provides third-party laboratory services and has an ultimate completion date of September...

<p>The National Heart Lung and Blood Institute (NHLBI), a civilian agency, has awarded a $29,740.00 firm fixed price purchase order contract to Applied Photophysics Inc. for a Q100 CD Spectrometer Service Agreement. The contract has a performance period ending on July 15, 2025. This contract is not set aside for any small business designation.</p>

The National Heart, Lung and Blood Institute (NHLBI) awarded a delivery order contract valued at $125,000 to Quest Diagnostics Incorporated for laboratory services supporting nationwide research participants enrolled in NHLBI clinical protocols. The contract, issued on January 5, 2026, operates on a firm fixed-price basis with a base period running from January 5, 2026 through January 4, 2027, followed by four option years extending through the ultimate completion date of January 4, 2031....

The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. government, awarded a $229,104 firm fixed-price purchase order contract to Psomagen Inc., a for-profit organization and manufacturer of goods. The contract, which has no set-aside designation, is for investigating transthyretin (TTR) variants and their impact on sickle cell disease severity using Olink proteomics technology. This contract is part of a larger $500 million single-award Indefinite Delivery...

The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $12,926 purchase order to Lakeshore Scientific, LLC for preventative maintenance of Agilent high-performance liquid chromatography equipment. The firm fixed price contract will provide maintenance services for HPLC systems located in Lake Forest, Illinois from September 5, 2023 through November 4, 2023. No subcontractors or set aside designations were identified. The...

The National Heart, Lung, and Blood Institute (NHLBI) awarded a $17,690.79 firm fixed-price BPA call to Qiagen, LLC on December 17, 2025, for delivery by March 16, 2026. The contract supports the Laboratory Applied Precision Omics program, which requires the QIAsymphony DSP Circulating DNA Kit to isolate cell-free DNA (cfDNA) from plasma samples collected from lung transplant patients. This award was issued without a set-aside designation, allowing Qiagen to compete in the open federal...

<p>The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $249,648.00 firm fixed price purchase order to Medical Neurogenetics, LLC, a for-profit organization, for clinical genetic testing services. The contract has a completion date of November 2, 2023 and does not have a set-aside designation. The place of performance is Bethesda, Maryland.</p>